1130 ECP Spotlight
BioCentury & Getty Images

Emerging Company Profile

Spotlight: solving CRISPR’s delivery challenges with RNPs

Emerging Company Profile: Spotlight developing tissue-targeted CRISPR therapies with $30M A round led by GV 

Spotlight emerged from stealth with a technology for tissue-targeted delivery of CRISPR therapies and a $30 million GV-led series A round.

Dec 1, 2020 | 12:23 AM GMT

Spotlight emerged from stealth on Monday with a $30 million series A round led by GV and a platform that could help address the challenge of systemically delivering CRISPR-based gene

Read the full 845 word article

How to gain access

Continue reading with a
two-week free trial.